1. Home
  2. EPOW vs CVKD Comparison

EPOW vs CVKD Comparison

Compare EPOW & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EPOW
  • CVKD
  • Stock Information
  • Founded
  • EPOW 2014
  • CVKD 2022
  • Country
  • EPOW China
  • CVKD United States
  • Employees
  • EPOW N/A
  • CVKD N/A
  • Industry
  • EPOW Business Services
  • CVKD Medicinal Chemicals and Botanical Products
  • Sector
  • EPOW Consumer Discretionary
  • CVKD Health Care
  • Exchange
  • EPOW Nasdaq
  • CVKD Nasdaq
  • Market Cap
  • EPOW 24.5M
  • CVKD 29.5M
  • IPO Year
  • EPOW 2021
  • CVKD 2023
  • Fundamental
  • Price
  • EPOW $0.98
  • CVKD $12.71
  • Analyst Decision
  • EPOW
  • CVKD Strong Buy
  • Analyst Count
  • EPOW 0
  • CVKD 1
  • Target Price
  • EPOW N/A
  • CVKD $32.00
  • AVG Volume (30 Days)
  • EPOW 17.7K
  • CVKD 35.8K
  • Earning Date
  • EPOW 07-22-2025
  • CVKD 08-06-2025
  • Dividend Yield
  • EPOW N/A
  • CVKD N/A
  • EPS Growth
  • EPOW N/A
  • CVKD N/A
  • EPS
  • EPOW N/A
  • CVKD N/A
  • Revenue
  • EPOW $64,997,741.00
  • CVKD N/A
  • Revenue This Year
  • EPOW N/A
  • CVKD N/A
  • Revenue Next Year
  • EPOW N/A
  • CVKD N/A
  • P/E Ratio
  • EPOW N/A
  • CVKD N/A
  • Revenue Growth
  • EPOW 44.28
  • CVKD N/A
  • 52 Week Low
  • EPOW $0.55
  • CVKD $5.70
  • 52 Week High
  • EPOW $1.36
  • CVKD $22.90
  • Technical
  • Relative Strength Index (RSI)
  • EPOW 54.02
  • CVKD 49.98
  • Support Level
  • EPOW $0.92
  • CVKD $11.00
  • Resistance Level
  • EPOW $0.96
  • CVKD $13.56
  • Average True Range (ATR)
  • EPOW 0.06
  • CVKD 1.15
  • MACD
  • EPOW 0.01
  • CVKD 0.25
  • Stochastic Oscillator
  • EPOW 62.50
  • CVKD 80.97

About EPOW Sunrise New Energy Co. Ltd

Sunrise New Energy Co Ltd is engaged in the manufacturing and sale of graphite anode material for EVs and other lithium-ion batteries. The Company's joint venture is in the construction of a manufacturing plant in Guizhou Province. The plant runs on inexpensive electricity from renewable sources that enables the group to be a low-cost and low environmental impact producer of graphite anode material, Its products include GS-1, GS-2, GS-3, GZD-1, GLD-1, and GZ-1.

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.

Share on Social Networks: